Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alnylam Pharmaceuticals Inc

+ Add to Watchlist

ALNY:US

116.9800 USD 4.3900 3.62%

As of 20:10:00 ET on 04/17/2015.

Snapshot for Alnylam Pharmaceuticals Inc (ALNY)

Open: 120.4500 Day's Range: 115.9700 - 121.0300 Volume: 835,664
Previous Close: 121.3700 52wk Range: 47.0300 - 123.7200 1-Yr Rtn: +117.19%

Stock Chart for ALNY

No chart data available.
  • ALNY:US 116.9800
  • 1D
  • 1M
  • 1Y
121.3700
Interactive ALNY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ALNY

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.8803
Est. EPS (USD) (12/2015) -2.9100
Est. PEG Ratio -
Market Cap (M USD) 9,825.25
Shares Outstanding (M) 83.99
30 Day Average Volume 678,532
Price/Book (mrq) 9.6459
Price/Sale (ttm) 173.5665
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ALNY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ALNY

Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.

John M MaraganoreChief Executive OfficerBarry E GreenePresident/COO
Akshay K VaishnawExec VP:Research & DevLaurie Bartlett KeatingSenior VP/Secretary/Gen Cnsl
More Company Profile & Key Executives for ALNY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil